Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Neurochemical Research
|
September 18, 2024
Correction: Nuclear Medicine Imaging Techniques in Glioblastomas
Emirhan Harbi, Michael Aschner
Molecular Biology Reports
|
March 5, 2025
Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategies
Emirhan Harbi, Michael Aschner
Cellular Oncology (Dordrecht, Netherlands)
|
December 10, 2024
Role of BRCA1 in glioblastoma etiology
Emirhan Harbi, Michael Aschner
Journal of Neuroendocrinology
|
March 5, 2025
Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma
Emirhan Harbi, Michael Aschner
Molecular Biology Reports
|
July 11, 2025
Potential role of terpenes in recovery from olfactory dysfunction with olfactory training: a review
Aytug Altundag, Emirhan Harbi
Neurochemical Research
|
September 5, 2024
Nuclear Medicine Imaging Techniques in Glioblastomas
Emirhan Harbi, Michael Aschner
JCO Precision Oncology
|
August 27, 2025
Use of Protein Arginine Methyltransferase Inhibitors in Gliomas
Emirhan Harbi, Christopher E Mason
Molecular Neurobiology
|
March 18, 2025
Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms
Emirhan Harbi, Ozcan Yildiz, Michael Aschner
The Laryngoscope
|
July 17, 2025
Terpene-Centered Olfactory Training in Postinfectious Olfactory Dysfunction: A Dual-Route Approach
Aytug Altundag, Emirhan Harbi, Melih Cayonu
Neurochemical Research
|
July 29, 2025
Intranasal Terpene Treatment for Glioblastoma: the Neuro-Oncological Potential of Perillyl Alcohol
Emirhan Harbi, Erhan Yarar, Christopher E Mason, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Neurochemical Research
|
September 18, 2024
Correction: Nuclear Medicine Imaging Techniques in Glioblastomas
Emirhan Harbi, Michael Aschner
Molecular Biology Reports
|
March 5, 2025
Von Hippel-Lindau syndrome: clinical features, genetic foundations, and management strategies
Emirhan Harbi, Michael Aschner
Cellular Oncology (Dordrecht, Netherlands)
|
December 10, 2024
Role of BRCA1 in glioblastoma etiology
Emirhan Harbi, Michael Aschner
Journal of Neuroendocrinology
|
March 5, 2025
Nuclear medicine and perspective thoughts in the diagnosis and treatment of pheochromocytoma and paraganglioma
Emirhan Harbi, Michael Aschner
Molecular Biology Reports
|
July 11, 2025
Potential role of terpenes in recovery from olfactory dysfunction with olfactory training: a review
Aytug Altundag, Emirhan Harbi
Neurochemical Research
|
September 5, 2024
Nuclear Medicine Imaging Techniques in Glioblastomas
Emirhan Harbi, Michael Aschner
JCO Precision Oncology
|
August 27, 2025
Use of Protein Arginine Methyltransferase Inhibitors in Gliomas
Emirhan Harbi, Christopher E Mason
Molecular Neurobiology
|
March 18, 2025
Potential Risks of Minoxidil in Pheochromocytoma and Paraganglioma: A Commentary on Safety Concerns and Mechanisms
Emirhan Harbi, Ozcan Yildiz, Michael Aschner
The Laryngoscope
|
July 17, 2025
Terpene-Centered Olfactory Training in Postinfectious Olfactory Dysfunction: A Dual-Route Approach
Aytug Altundag, Emirhan Harbi, Melih Cayonu
Neurochemical Research
|
July 29, 2025
Intranasal Terpene Treatment for Glioblastoma: the Neuro-Oncological Potential of Perillyl Alcohol
Emirhan Harbi, Erhan Yarar, Christopher E Mason, et al.
Page
of 2